• Consensus Rating: Buy
  • Consensus Price Target: $10.00
  • Forecasted Upside: 166.67 %
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$3.75
▲ +0.03 (0.81%)

This chart shows the closing price for MTBC by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New CareCloud Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MTBC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MTBC

Analyst Price Target is $10.00
▲ +166.67% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for CareCloud in the last 3 months. The average price target is $10.00, with a high forecast of $12.00 and a low forecast of $8.00. The average price target represents a 166.67% upside from the last price of $3.75.

This chart shows the closing price for MTBC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 2 polled investment analysts is to buy stock in CareCloud. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 9 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/23/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/24/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/22/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/20/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/18/2022
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/19/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/18/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/17/2022

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/15/2022BenchmarkLower Target$12.00N/A
8/5/2022B. RileyLower Target$11.00 ➝ $8.00Low
5/9/2022Roth CapitalReiterated RatingBuyHigh
3/15/2022B. RileyLower TargetBuy$18.00 ➝ $11.00High
8/11/2021B. RileyReiterated RatingBuy$20.00Medium
8/6/2021Maxim GroupReiterated RatingBuy$20.00Low
6/11/2021Cantor FitzgeraldInitiated CoverageOverweight$15.00High
5/17/2021B. RileyReiterated RatingBuy$20.00Low
1/28/2021Maxim GroupInitiated CoverageBuy$20.00High
8/18/2020HC WainwrightBoost TargetBuy$10.00 ➝ $14.00Medium
8/14/2020Colliers SecuritiesBoost TargetBuy$12.50 ➝ $13.50Low
8/10/2020B. RileyBoost TargetBuy ➝ Buy$8.50 ➝ $15.50High
7/27/2020LADENBURG THALM/SH SHBoost TargetBuy ➝ Buy$10.05High
7/22/2020HC WainwrightBoost TargetBuy ➝ Buy$10.00 ➝ $10.95Medium
7/21/2020BenchmarkReiterated RatingBuy$15.00High
7/10/2020BenchmarkInitiated CoverageBuy$15.00Low
7/8/2020Colliers SecuritiesSet TargetBuy$12.50High
7/2/2020Roth CapitalInitiated CoverageBuyHigh
6/22/2020HC WainwrightUpgradeNeutral ➝ Buy$10.00High
6/18/2020B. RileyReiterated RatingBuy$8.50High
6/2/2020LADENBURG THALM/SH SHInitiated CoverageBuyHigh
5/15/2020HC WainwrightReiterated RatingNeutral ➝ Neutral$6.00 ➝ $6.40Low
5/15/2020Dougherty & CoReiterated RatingBuy ➝ Buy$7.50Low
5/15/2020B. RileyBoost TargetBuy$8.00 ➝ $8.50Low
5/14/2020National SecuritiesReiterated RatingBuy$8.00Medium
3/2/2020HC WainwrightDowngradeBuy ➝ Neutral$6.00High
1/9/2020B. RileyReiterated RatingBuy$6.25Low
12/13/2019B. RileyReiterated RatingBuy$6.25Medium
12/3/2019B. RileyInitiated CoverageBuy$6.25High
10/15/2019HC WainwrightReiterated RatingBuy$6.00Low
10/10/2019National SecuritiesInitiated CoverageBuy$6.00 ➝ $6.00Medium
5/9/2019HC WainwrightReiterated RatingBuyMedium
4/5/2019HC WainwrightSet TargetBuy$6.00Low
3/21/2019HC WainwrightReiterated RatingBuyLow
3/15/2019Dougherty & CoInitiated CoverageBuyMedium
1/23/2019HC WainwrightSet TargetBuy$6.00High
11/8/2018HC WainwrightSet TargetBuy$6.00Low
8/13/2018HC WainwrightSet TargetBuy$6.00Low
7/2/2018HC WainwrightSet TargetBuy$6.00Medium
5/16/2018HC WainwrightSet TargetBuy$5.00Low
5/5/2018Chardan CapitalReiterated RatingBuy ➝ Buy$2.75High
5/5/2018Summer StreetReiterated RatingBuy ➝ BuyHigh
3/8/2018HC WainwrightReiterated RatingBuy$5.00High
3/2/2018HC WainwrightInitiated CoverageBuy ➝ BuyMedium
11/14/2017Chardan CapitalBoost TargetBuy ➝ Buy$2.25 ➝ $2.75N/A
(Data available from 8/18/2017 forward)

News Sentiment Rating

0.04 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
1/20/2022
  • 6 very positive mentions
  • 10 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
2/19/2022
  • 0 very positive mentions
  • 5 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
3/21/2022
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/20/2022
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/20/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/19/2022
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/19/2022
  • 1 very positive mentions
  • 9 positive mentions
  • 4 negative mentions
  • 0 very negative mentions
8/18/2022

Current Sentiment

  • 1 very positive mentions
  • 9 positive mentions
  • 4 negative mentions
  • 0 very negative mentions
CareCloud logo
CareCloud, Inc. brings disciplined innovation to the business of healthcare. Our suite of technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows, and make better business and care decisions. More than 40,000 providers across the United States count on CareCloud to help them improve patient care while reducing administrative burdens and operating costs. Services and solutions include revenue cycle management (RCM), practice management (PM), electronic health record (EHR), business intelligence, telehealth, and patient experience management (PXM). CareCloud is headquartered in Somerset, NJ.
Read More

Today's Range

Now: $3.75
Low: $3.70
High: $3.75

50 Day Range

MA: $3.73
Low: $3.37
High: $4.33

52 Week Range

Now: $3.75
Low: $3.25
High: $8.90

Volume

402 shs

Average Volume

41,150 shs

Market Capitalization

$56.55 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.18

Frequently Asked Questions

What sell-side analysts currently cover shares of CareCloud?

The following Wall Street sell-side analysts have issued reports on CareCloud in the last twelve months: B. Riley, Benchmark Co., Roth Capital, StockNews.com, and TheStreet.
View the latest analyst ratings for MTBC.

What is the current price target for CareCloud?

2 Wall Street analysts have set twelve-month price targets for CareCloud in the last year. Their average twelve-month price target is $10.00, suggesting a possible upside of 166.7%. Benchmark Co. has the highest price target set, predicting MTBC will reach $12.00 in the next twelve months. B. Riley has the lowest price target set, forecasting a price of $8.00 for CareCloud in the next year.
View the latest price targets for MTBC.

What is the current consensus analyst rating for CareCloud?

CareCloud currently has 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe MTBC will outperform the market and that investors should add to their positions of CareCloud.
View the latest ratings for MTBC.

What other companies compete with CareCloud?

How do I contact CareCloud's investor relations team?

CareCloud's physical mailing address is 7 CLYDE ROAD, SOMERSET NJ, 08873. The technology company's listed phone number is 732-873-5133. The official website for CareCloud is www.carecloud.com. Learn More about contacing CareCloud investor relations.